FDA ISSUES DRAFT GUIDANCE ON INDS FOR PET DRUGS

The FDA has announced the availability of a draft guidance document entitled, “Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs”.

The draft guidance is intended to assist manufacturers of PET drugs in submitting investigational new drug applications (INDs). The draft guidance summarizes the IND process for PET drugs, makes recommendations for how to submit an IND, provides advice on expanded access options for investigational PET drugs, and describes the process for requesting permission to charge for an investigational PET drug.

Comments will be accepted until May 14, 2012 and may be submitted in writing or electronically through http://www.regulations.gov (Search Docket No. FDA-2012-D-0081).

To view the draft guidance: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM291573.pdf

Advertisements
This entry was posted in PET Drugs. Bookmark the permalink.

One Response to FDA ISSUES DRAFT GUIDANCE ON INDS FOR PET DRUGS

  1. “FDA ISSUES DRAFT GUIDANCE ON INDS FOR PET DRUGS |” ended
    up being a wonderful article and I actually was in fact very satisfied to come across the blog.
    Thanks,Ericka

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s